Compare GHI & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests
Current Price
| Metric | GHI | TMCI |
|---|---|---|
| Founded | 1998 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 161.5M | 174.6M |
| IPO Year | N/A | 2021 |
| Metric | GHI | TMCI |
|---|---|---|
| Price | $7.13 | $2.49 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 5 |
| Target Price | ★ $13.00 | $4.96 |
| AVG Volume (30 Days) | 202.0K | ★ 903.1K |
| Earning Date | 02-19-2026 | 11-06-2025 |
| Dividend Yield | ★ 21.48% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.17 | N/A |
| Revenue | $26,247,399.00 | ★ $218,879,000.00 |
| Revenue This Year | $201.02 | $3.25 |
| Revenue Next Year | $2.87 | $0.99 |
| P/E Ratio | $40.84 | ★ N/A |
| Revenue Growth | N/A | ★ 7.90 |
| 52 Week Low | $6.01 | $2.36 |
| 52 Week High | $13.29 | $10.79 |
| Indicator | GHI | TMCI |
|---|---|---|
| Relative Strength Index (RSI) | 53.00 | 32.97 |
| Support Level | $6.52 | $2.40 |
| Resistance Level | $7.35 | $2.56 |
| Average True Range (ATR) | 0.37 | 0.16 |
| MACD | 0.06 | 0.07 |
| Stochastic Oscillator | 69.74 | 22.40 |
Greystone Housing Impact Investors LP engaged in acquiring a portfolio of mortgage revenue bonds (MRBs) that are issued by state and local housing authorities to provide construction and/or permanent financing for affordable multifamily housing, seniors housing, and commercial properties. It has four reportable segments, namely Affordable Multifamily MRB Investments, Seniors and Skilled Nursing MRB Investments, MF Properties, and Market-Rate Joint Venture Investments. It generates the majority of its revenue from the Affordable Multifamily MRB Investments segment.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.